| Helicobacter pylori-related gastroenterology studies | Lifetime | 304 | IR 2 | 98.74 |
| Hepatitis B Virus Studies | Lifetime | 541 | IR 3 | 98.55 |
| Gastrointestinal disorders and treatments | Lifetime | 524 | IR 1 | 97.91 |
| Hepatitis C virus research | Lifetime | 739 | IR 4 | 98.08 |
| Gastric Cancer Management and Outcomes | Lifetime | 993 | IR 2 | 98.15 |
| Genetic factors in colorectal cancer | Lifetime | 720 | IR 1 | 97.62 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 349 | IR 1 | 97.40 |
| Galectins and Cancer Biology | Lifetime | 372 | IR 1 | 96.35 |
| Celiac Disease Research and Management | Lifetime | 233 | IR 3 | 96.68 |
| Colorectal Cancer Screening and Detection | Lifetime | 794 | IR 3 | 97.29 |
| Microscopic Colitis | Lifetime | 499 | IR 1 | 97.47 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 398 | IR 2 | 96.26 |
| Inflammatory Bowel Disease | Lifetime | 953 | IR 3 | 96.29 |
| Veterinary medicine and infectious diseases | Lifetime | 250 | IR 1 | 95.61 |
| Parasitic Infections and Diagnostics | Lifetime | 586 | IR 11 | 95.80 |
| Amoebic Infections and Treatments | Lifetime | 396 | IR 7 | 93.59 |
| Parasitic infections in humans and animals | Lifetime | 710 | IR 32 | 90.71 |
| Whipple's Disease and Interleukins | Lifetime | 546 | IR 5 | 64.93 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 269 | IR 3 | 98.59 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 63 | IR 2 | 96.15 |
| Liver physiology and pathology | 2021-2025 | 45 | IR 2 | 94.24 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 169 | IR 5 | 95.28 |
| Gut microbiota and health | 2021-2025 | 930 | IR 11 | 94.40 |
| Extracellular vesicles in disease | 2021-2025 | 629 | IR 21 | 92.19 |
| Parasitic Infections and Diagnostics | 2021-2025 | 143 | IR 18 | 91.96 |
| Microscopic Colitis | 2021-2025 | 650 | IR 3 | 90.26 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 534 | IR 2 | 85.95 |
| Gastrointestinal disorders and treatments | 2021-2025 | 717 | IR 1 | 84.04 |
| Celiac Disease Research and Management | 2021-2025 | 226 | IR 6 | 85.87 |
| Gastrointestinal motility and disorders | 2021-2025 | 472 | IR 6 | 85.78 |
| Amoebic Infections and Treatments | 2021-2025 | 109 | IR 8 | 82.56 |
| Diet, Metabolism, and Disease | 2021-2025 | 775 | IR 43 | 83.57 |
| Liver Diseases and Immunity | 2021-2025 | 534 | IR 2 | 84.15 |
| Toxoplasma gondii Research Studies | 2021-2025 | 291 | IR 28 | 83.17 |
| Galectins and Cancer Biology | 2021-2025 | 357 | IR 8 | 78.80 |
| Parasitic infections in humans and animals | 2021-2025 | 260 | IR 25 | 78.71 |
| Lipid metabolism and disorders | 2021-2025 | 693 | IR 12 | 65.52 |
| Digestive system and related health | 2021-2025 | 849 | IR 11 | 59.70 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 814 | IR 29 | 58.87 |
